InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.50%
)
Bitcoin
91,368.30
(
0.34%
)
Post# of 253623
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 478
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: None

Wednesday, 06/23/2010 6:23:09 PM

Wednesday, June 23, 2010 6:23:09 PM

Post# of 253623
Status of QAB149 - Onbrez for COPD.

I know NVS got a complete response letter from FDA last October. Apparently FDA wanted additional information on dosing. Anyone know the status of NVS' response or how long might be anticipated to respond.

I know the drug was approved in the EU but I can't tell whether additional trials were necessary in the US or just re-analysis of existing data.

Thanks FL
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up